Abstract
While some salicylates (salicyclic acid and salicylaldehyde, especially) are as potent as aspirin as acute, orally-active anti-inflammatory drugs in the rat, they are either inactive or far less potent as PG synthesis inhibitors when added directly to isolated platelets or when given orally.
Although PGE1 and PGE2 produce anti-ulcerogenic effects when given to rats in the presence of selected nonsteroidal anti-inflammatory drugs, they fail to inhibit the acute anti-inflammatory and anti-nociceptive effects of these drugs. They are anti-inflammatory and anti-nociceptive under certain experimental conditions. PGE1 and PGE2 can also behave as hypothermic agents when given subcutaneously. Related studies, using PG synthesis stimulators in vivo and in vitro (substituted phenylureas), also cause anti-nociception and hypothermia.
All of these indirect studies, when taken together, infer that PG synthesis inhibitionper se fails to explain, entirely, the pharmacologic effects of non-steroidal anti-inflammatory drugs. They also suggest that the precise role of certain PGs in toxicopharmacology is far from simple and straightforward.
Similar content being viewed by others
References
S.H. Ferreira andJ.R. Vane,New Aspects of the Mode of Action of Non-Steroidal Anti-Inflammatory Drugs, Ann. Rev. Pharmac.14, 57–71 (1974).
J.R. Vane,Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-Like Drugs, Nature, New Biol.231, 232–235 (1971).
J.R. Vane,The Mode of Action of Aspirin-Like Drugs, Agents and Actions8(4), 430–431 (1978).
M.J.H. Smith,Aspirin and Prostaglandins: Some Recent Developments, Agents and Actions8(4), 427–429 (1978).
P.L. Boardman andF.D. Hart,Clinical Measurements of the Anti-Inflammatory Effects of Salicylate in Rheumatoid Arthritis, Br. Med. J.4, 264–268 (1967).
D. Crook, A.J. Collins, P.A. Bacon andR. Chan,Prostaglandin Synthetase Activity for Human Rheumatoid Synovial Microsomes, Ann. Rheum. Dis.35, 327–332 (1976).
A. Blackman, H. Radzivonik andJ. Westwick,The Effects of Drugs in Established Monoarticular Arthritis, Agents and Actions7, 473–480 (1977).
S.H. Ferreira,Prostaglandins and Non-Steroidal Anti-Inflammatory Drugs, in:Prostaglandins and Thromboxanes (Eds. F. Berti, B. Samuellson and G.P. Velo; Plenum Press, New York, 1977), pp. 353–361.
J.R. Walker, M.J.H. Smith andA.W. Ford-Hutchinson,Anti-Inflammatory Drugs, Prostaglandins and Leucocyte Migration, Agents and Actions6, 602–606 (1976).
I. Rivkin, G.V. Foschi andC.H. Rosen,Inhibition of Neutrophil Chemotaxis and Spontaneous Mobility by Anti-Inflammatory Agents, Proc. Soc. Exp. Biol. Med.153, 236 (1976).
R.J. Flower,Prostaglandins and Related Compounds, in:Inflammation Mechanisms and their Impact on Therapy (Eds. I.L. Bonta, J. Thompson and K. Brune; Birkhäuser Verlag, Basel, 1977), pp. 99–106.
S. Moncada andJ.R. Vane,Interactions Between Anti-Inflammatory and Inflammatory Mediators. A Reference to Products of Arachidonic Acid Metabolism, in:Inflammation: Mechanisms and their Impact on Therapy (Eds. I.L. Bonta, J. Thompson and K. Brune; Birkhäuser Verlag, Basel, 1977), pp. 141–148.
S.H. Ferreira, B.B. Lorenzetti, M. Salete, A. Castro andF.M.D. Corea,Antialgic Effects of Aspirin-Like Drugs and the Inhibition of Prostaglandin Synthesis, in:Recognition of Anti-Rheumatic Drugs (Eds. D.C. DuMonde and M.K. Jasare, 1977), pp. 25–37.
K.T. Kirton, J.C. Cornette andK.L. Barr,Characterization of Antibody to PGF 2α. Biochem. Biophys. Res. Comm.47, 903 (1971).
R. Jaques,Antagonism of Non-Steroidal Anti-Inflammatory Drugs and Analgesics Against Ethacrynic Acid Induced Writhing, Arzneim-Forsch Drug Res.27 (II), 1698 (1977).
A. Robert, J.E. Nezamis andJ.P. Phillips,Effect of PGE 1 on Gastric Secretion and Ulcer Formation in the Rat, Gastroenterology55 (4), 481–487 (1968).
A. Robert, J.R. Schultz, J.E. Nezamis andC. Lancaster,Gastric Anti-Secretory and Antiulcer Properties of PGE 2,15-Methyl PGE 2 and 16,16-Dimethyl PGE 2, Gastroenterology70, 359–370 (1976).
E.M. Glenn, D.A. Rector, B.J. Bowman andN.A. Rohloff,Urea Compounds that increase Biosynthesis of PGs In Vitro-In Vivo, Agents and Actions7 (5/6), 517–528 (1977).
J.C. McGiff, K.U. Malik andN.A. Teragno,Prostaglandins as Determinants of Vascular Reactivity, Fed. Proc.35, 2382 (1976).
R.J. Flower,Drugs Which Inhibit Prostaglandin Biosynthesis, Pharmac. Rev.26, 33 (1974).
S.H. Ferreira andJ.R. Vane,New Aspects of the Mode of Action of Non-Steroid Anti-Inflammatory Drugs, Ann. Rev. Pharmac.14, 57–73 (1974).
E.M. Glenn, B.J. Bowman andN.A. Rohloff,Anti-Inflammatory and PG Inhibitory Effects of Phenacetin and Acetaminophen, Agents and Actions7 (5/6), 513–516 (1977).
J.P. Famaey,Recent Developments about Non-Steroidal Anti-Inflammatory Drugs and Their Mode of Action, General Pharmac.9, 155–161 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glenn, E.M., Bowman, B.J. & Rohloff, N.A. Anomalous biological effects of salicylates and prostaglandins. Agents and Actions 9, 257–264 (1979). https://doi.org/10.1007/BF01966698
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01966698